FDA Sends Letter to Novartis Regarding Promotional Material for Focalin XR - Drugs.com MedNews
Links shared publicly online about this topic.
- 198total visits
FDA Sends Letter to Novartis Regarding Promotional Material for Focalin XR - Drugs.com MedNews
The FDA posted on its website a letter sent to Novartis Pharmaceuticals regarding promotional material for ADHD drug Focalin XR. The letter is below. Joyce Pash
View full resource at drugs.com
Tags: ADHD, ADHD Medication, Drug, Pharma, FDA, Focalin, Novartis
Most Recently Shared on June 23, 2011 at 3:14 pm By:
FDA Sends Letter to Novartis Regarding Promotional Material for Focalin XR: SILVER SPRING, Md., Jun 23 201... http://bit.ly/m3MAWr #drug
Advertisement
